244 related articles for article (PubMed ID: 25185728)
1. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
Geetha D; Kallenberg C; Stone JH; Salama AD; Appel GB; Duna G; Brunetta P; Jayne D
J Nephrol; 2015 Feb; 28(1):17-27. PubMed ID: 25185728
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?
Tesar V; Hruskova Z
Clin J Am Soc Nephrol; 2020 Oct; 15(10):1519-1521. PubMed ID: 32471814
[No Abstract] [Full Text] [Related]
3. How best to manage relapse and remission in ANCA-associated vasculitis.
Puéchal X; Guillevin L
Expert Rev Clin Immunol; 2022 Nov; 18(11):1135-1143. PubMed ID: 36102147
[TBL] [Abstract][Full Text] [Related]
4. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
Singer O; McCune WJ
Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
7. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
8. Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis.
Berti A; Cornec D; Dua AB
Rheum Dis Clin North Am; 2023 Aug; 49(3):545-561. PubMed ID: 37331732
[TBL] [Abstract][Full Text] [Related]
9. [Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis].
de Groot K; Aries PM; Haubitz M; Hellmich B; Lamprecht P; Thiel J
Dtsch Med Wochenschr; 2020 Jan; 145(1):40-46. PubMed ID: 31914468
[TBL] [Abstract][Full Text] [Related]
10. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Stone JH; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Turkiewicz A; Tchao NK; Webber L; Ding L; Sejismundo LP; Mieras K; Weitzenkamp D; Ikle D; Seyfert-Margolis V; Mueller M; Brunetta P; Allen NB; Fervenza FC; Geetha D; Keogh KA; Kissin EY; Monach PA; Peikert T; Stegeman C; Ytterberg SR; Specks U;
N Engl J Med; 2010 Jul; 363(3):221-32. PubMed ID: 20647199
[TBL] [Abstract][Full Text] [Related]
11. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
12. Novel Therapies for ANCA-associated Vasculitis.
Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
[TBL] [Abstract][Full Text] [Related]
13. [Update on treatment of ANCA-associated vasculitis: Granulomatosis with polyangiitis and Microscopic Polyangiitis].
Holle JU; Hellmich B; Moosig F
Z Rheumatol; 2022 May; 81(4):280-285. PubMed ID: 35061059
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis.
Harigai M; Tsutsumino M; Takada H; Nagasaka K
Korean J Intern Med; 2019 May; 34(3):492-503. PubMed ID: 30613065
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
Langford CA
Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):31-4. PubMed ID: 21447129
[TBL] [Abstract][Full Text] [Related]
16. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
[TBL] [Abstract][Full Text] [Related]
17. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
[TBL] [Abstract][Full Text] [Related]
18. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
19. [ANCA-associated vasculitis].
Krasselt ML; Holle JU
Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
[TBL] [Abstract][Full Text] [Related]
20. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
Santana AN; Woronik V; Halpern AS; Barbas CS
J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]